MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland – January 22, 2024

MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL) approval from Health Canada.

The collaboration authorizes Medron Medical Systems to distribute MVision AI’s products and services throughout Canada.

Ronald Wallace, President of Medron Medical Systems Inc., commented on the evolving landscape of radiation oncology, stating, “Innovation and the introduction of new modalities in radiation oncology have changed the landscape in how Radiation Therapy is delivered. The introduction of artificial intelligence (AI) in treatment planning is the beginning of a new era that will assist clinicians to offer unprecedented precision and personalized care to patients, marking a significant leap forward in advancing the field of radiation oncology.

With a shared commitment to enhancing oncology departments’ workflow, both companies aim to deliver the world’s first comprehensive solution for AI radiotherapy contouring, comprising three innovative products – Contour+, Guide, and Verify.

Stewart Pegrum, Vice President Global Sales at MVision AI, highlighted the company’s rapid expansion and expressed excitement about initiating this partnership with Medron Medical Systems for Canadian hospitals. He stated, “We are already assisting our customers to fulfill their desires to deliver same day treatment for their patients. I am delighted that in collaboration with Medron, we can now offer this service to the patients of Canada.”

For additional inquiries on Medron Medical System:

Medron Medical Systems Inc. is a Canadian company that specializes in providing quality products and services to healthcare professionals, particularly in the fields of Radiological Imaging, Nuclear Medicine, Radiation Oncology, and Medical Physics. The company is a leader in the Canadian healthcare sector, offering a range of medical equipment and solutions to healthcare facilities throughout the country​​​​.

Website: medron.ca

Email: info@medron.ca

Twitter page: @medronmedical

Tel: +1 613-769-3302

Learn more about incorporating MVision AI’s GBS™ solution:

MVision AI is your trusted partner in healthcare innovation! We are a team of experienced professionals committed to revolutionizing the cancer care industry through the application of cutting-edge AI technology. At MVision AI, we understand the challenges faced by healthcare providers in delivering accurate, timely, and efficient cancer care to patients. That’s why we are developing a suite of AI-powered solutions that can help streamline radiation therapy workflows, enable treatment quality and lead to standardization.

Website: MVision.ai

Email: sale@mvision.ai

Linkedin page: @mvisionai

Twitter page: @mvisionai

Facebook page: @mvsionai

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

2.7.2024

Breaking New Ground: MVision AI Contour+ for Upright MRI Scans

Results on testing MVision AI Contour+ for an ingenious and modern approach in radiation therapy have been recently presented at the 62nd Particle Therapy Co-Operative Group (PTCOG) conference in Singapore. Despite being trained using supine MR data and a different magnetic strength from different scanners, authors reported that MVision AI's…

Articles

28.6.2024

AI Role in Improving Contouring Skills of Radiation Oncologists—Results From a Large International Project

Many regions of the globe face significant disparities between the need of radiation therapy and its availability [1]. Another challenge is providing adequate training for radiation oncology professionals [2]. The cancer burden is expected to rise everywhere, especially the low- and middle-income countries [3]. Artificial intelligence offers a wide range…

Articles

20.6.2024

World Kidney Cancer Day 2024: “Listen”

World Kidney Cancer Day is observed every year on the second Thursday of June. “Listening” is this year’s theme, which refers to the benefits of shared decision making, patient’s empowerment to seek a second opinion and creating awareness around misinformation and how to check if sources are reliable (1). More…

News